
20 Sept 2026, 7 min read
From term sheet to money in the bank
Getting a term sheet feels like the finish line. It is the point where the real work starts, and the gap between signing and seeing the money is usually six to ten weeks.
The terms of a deal decide more than its price does.
A deal is a structure before it is a price: who owns what, on what conditions, and what happens at the next round or sale. Getting that wrong is expensive, and the cost does not show until years later.
Mainly for
We work for both. For investors, we find companies, check them, and support the ones you back. For companies, we prepare you for the checks you are about to face. We also get you ready so a stock market listing becomes a plan, not just a hope.
Before
For the company
The financial model, the pitch deck and the market case that hold up in a second meeting.
For the investor
Companies from founders we already work with, checked against what you invest in.
Diligence
For the company
Ready before an investor or buyer starts checking, not while they are.
For the investor
We check the finances, legal papers, operations and market, from start to finish.
Terms
For the company
The kind of shares or notes you issue, the terms, and the effects that outlast the headline price.
For the investor
Shaping a deal and testing what it is really worth.
A gap an investor discovers tends to become a price discussion. (read where we wrote it)
After
For the company
The board practices, reporting and controls a stock market listing needs, in place well before you list.
For the investor
A finance and reporting team behind the companies you hold, so their growth in value is managed, not hoped for.
Shaping the deal, reviewing the term sheet, and keeping every party moving until it closes.
A term sheet is two pages. It decides the next ten years of your company.

Live mandates
Companies we are working with now, open to the right investor. Ask us for the detail behind any of them.
Live mandate
Agritech equipment manufacturer improving farm productivity through mechanized solutions. Targets modern agriculture demand with scalable manufacturing.
Live mandate
Deep-tech MedTech developing advanced medical devices across neuroscience, oncology, and cardiovascular care. Combines engineering with regulatory expertise.
Live mandate
Digital health platform connecting healthcare delivery, preventive care, and wellness. Scalable tech-enabled model addressing accessibility gaps.
Live mandate
Industrial AI platform helping manufacturers monitor assets, reduce downtime, and improve efficiency through predictive analytics and IoT.
Live mandate
AI-powered finance operations platform automating accounting, workflows, and reporting for enterprises. B2B SaaS with strong efficiency value proposition.

20 Sept 2026, 7 min read
Getting a term sheet feels like the finish line. It is the point where the real work starts, and the gap between signing and seeing the money is usually six to ten weeks.

20 Sept 2026, 9 min read
Founders negotiate valuation for weeks and these two clauses in about ten minutes. Valuation sets the headline; liquidation preference and anti-dilution decide what you actually receive.

20 Sept 2026, 7 min read
Most founders choose a structure on cost. The real cost of the decision is not the registration fee but what you pay to change your mind later, at a moment when you have no time.

23 Sept 2026, 8 min read
Founders treat a holding-company move as paperwork. Five things break when they do, and four of them surface at the next diligence rather than now.

21 May 2026, 3 min read
When founders prepare for due diligence, most of the focus goes into financial DD. This is necessary work, and it is also incomplete. Financial DD tests what the company has been. Commercial DD tests what the company is.

21 May 2026, 3 min read
Revenue is the most-watched number in a growing company. And in most growing companies, it is slightly wrong. Not wrong in a fraud sense. Wrong in a controllership sense.
Running an accelerator or a corporate venture programme? See Strategy Labs.
From Sriram Chidambaram, Founder & Managing Partner
What causes delay, renegotiation and occasionally a dead deal is almost never the company’s performance. It’s the record of the company: the documents, the filings, the registers, the contracts.
Enterprise value isn’t built on a founder’s confidence. It’s built on numbers that hold up when someone who doesn’t trust you examines them.
